Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 1, 2000, Pages 23-28

  Deguchi, Katsumi ^a   Deguchi, Akira ^c   Wada, Hideo ^a   Murashima, Seiko ^b  

^a MIE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MIE PREFECTURAL COLLEGE OF NURSING   (Japan)

^c NONE

Author keywords

Cardiovascular diseases; Cardiovascular risk factors; Elderly; Hemostatic molecular markers

Indexed keywords

ALPHA 2 ANTIPLASMIN; D DIMER; FIBRIN MONOMER; PLASMIN; THROMBIN ANTITHROMBIN COMPLEX; THROMBOMODULIN;

AGED; AGING; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DAILY LIFE ACTIVITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR;

AGED; AGED, 80 AND OVER; AGING; ANTIFIBRINOLYTIC AGENTS; ANTIPLASMIN; ANTITHROMBIN III; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; COMORBIDITY; DIABETES MELLITUS; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; HEMOSTASIS; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; OBESITY; PEPTIDE HYDROLASES; PLASMIN; RISK FACTORS; THROMBOMODULIN;

EID: 0034088973     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. 1. Kario K, Matsuo T, Kobayashi H. Which factors affect high D-dimer levels in the elderly? Thromb Res 1991;62:501-508
2. 2. Deguchi A, Deguchi K, Shimura M, et al. Spa bathing activates fibrinolysis in patients with cerebral infarction. Intern Med 1993;32:619-622
3. 3. Deguchi A, Ohnishi K, Nakagawa H, et al. Lipoprotein(a) and effective renal plasma flow rate in older patients with arteriosclerotic diseases. JAGS 1995;43:1067-1068
4. 4. Deguchi K, Izumi K, Noguchi M, Wada H, Shirakawa S. Response of the cubital vein to occlusion and calcification of the abdominal aorta in patients with chronic renal failure on maintenance hemodialysis. Thromb Res 1988;49:69-77
5. 5. Deguchi K, Izumi K, Noguchi M, et al. Coagulation and fibrinolysis in patients with chronic renal failure on maintenance hemodialysis. Acta Haematol Jpn 1989;52:140-146
6. 6. Cushman M, Psaty BM, Macy E, et al. Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease. Arterioscler Thromb Vasc Biol 1996;16:1163-1169
7. 7. DeSouza CA, Jones PP, Seals DR. Physical activity status and adverse age-related differences in coagulation and fibrinolytic factors in women. Arterioscler Thromb Vasc Biol 1998;18: 362-368
8. 8. Deguchi K, Noguchi M, Iwasaki E, et al. Dynamic fluctuations in blood of thrombin/antithrombin III complex (TAT). Am J Hematol 1991;38:86-89
9. 9. Deguchi K, Tsukada T, Oonishi K, Murashima S, Nishikawa M. Study on hyperactivated state of coagulation and fibrinolysis. In: Shen M-C, Teng C-M, Takada A, eds. Current Aspects of Blood Coagulation, Fibrinolysis and Platelets. Tokyo: Springer-Verlag 1993;93-97
10. 10. Deguchi A, Ohnishi K, Nakamura S, et al. Plasma thrombomodulin values and hepatorenal function in the elderly. Arch Gerontol Geriatr 1997;24:47-54
11. 11. Kapiotis S, Jilma B, Quehenberger P, et al. Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex. Circulation 1997;96:19-21
12. 12. Mari D, Mannucci PM, Coppola R, et al. Hypercoagulability in centenarians: the paradox of successful aging. Blood 1995;85: 3144-3149
13. 13. Bijnen FCH, Feskens EJM, Giampaoli S, et al. Haemostatic parameters and lifestyle factors in elderly men in Italy and The Netherlands. Thromb Haemost 1996;76:411-416